In the population-based Icelandic Genome Study, 0.2% of participants had a polymorphism in this gene which was associated with cirrhosis and elevated serum levels of liver-related biomarkers, ALT, AST, and GGT [25]. The gene discussed is GPT; the disease is Cirrhosis.